Cost and Quality

Latest California Healthline Stories

More Sickle Cell Patients Survive, But Care Is Hard To Find For Adults

For many years, most people with sickle cell died in childhood or adolescence, and the condition remained in the province of pediatrics. During the past two decades, advances in routine care have allowed many people to live into middle age and beyond, but barriers to care remain.

Pharmaceutical Company Has Hiked Price On Aid-In-Dying Drug

Valeant Pharmaceuticals, the company that makes Seconal, the drug most commonly used in prescribed for terminally ill patients who want to end their lives, physician-assisted suicide, has doubled the price to more than $3,000.